The significant constitutive hepatic expression of ferroportin documented in this study reinforces the role of the liver as a regulator of iron levels, by increasing its release during conditions of limited iron availability (such as anemia, hypoxia, iron-poor diet) or blocking its export during conditions of iron overload or infection/inflammation. This evidence concerns the gene SLC40A1 and anemia (phenotype).